Mavenclad vs. Rebif

Reviewed on 12/11/2020

Are Mavenclad and Rebif the Same Thing?

Mavenclad (cladribine) and Rebif (interferon beta-1a) Injection used to treat relapsing forms of multiple sclerosis (MS).

Because of its safety profile, use of Mavenclad is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS.

Mavenclad and Rebif belong to different drug classes. Mavenclad is a purine antimetabolite and Rebif is made from human proteins.

Side effects of Mavenclad that are different from Rebif include upper respiratory tract infection, headache, low white blood cell count (lymphopenia), nausea, back pain, joint pain, and insomnia.

Side effects of Rebif that are different from Mavenclad include injection site reactions (pain, swelling, or redness) and flu-like symptoms (headache, dizziness, fatigue, fever, chills, stomach pain, runny or stuffy nose, and muscle aches). Some patients using interferon medications such as Rebif become depressed or have suicidal thoughts.

Mavenclad may interact with immunosuppressive drugs, hematotoxic drugs, antiviral and antiretroviral drugs, ritonavir, eltrombopag, curcumin, cyclosporine, dilazep, nifedipine, nimodipine, cilostazol, sulindac, dipyridamole, reserpine, interferon-beta, corticosteroids, rifampicin, St. John's wort, and hormonal contraceptives.

Rebif may interact with other drugs.

What Are Possible Side Effects of Mavenclad?

Common side effects of Mavenclad include:

  • upper respiratory tract infection,
  • headache,
  • low white blood cell count (lymphopenia),
  • nausea,
  • back pain,
  • joint pain, and
  • insomnia

What Are Possible Side Effects of Rebif?

Common side effects of Rebif include pain, swelling, or redness at the injection site. Flu-like symptoms such as headache, dizziness, fatigue, fever, chills, stomach pain, runny or stuffy nose, and muscle aches may occur when you first start Rebif. These symptoms usually improve or go away after a few months of continued use of Rebif. Some patients using interferon medications such as Rebif become depressed or have suicidal thoughts. Tell your doctor immediately if this occurs. Tell your doctor if you have serious side effects of Rebif including:

  • mental/mood changes (e.g., depression, rare thoughts of suicide),
  • vision changes,
  • gradual change in weight,
  • intolerance to cold or heat,
  • increased urination,
  • pus or change in skin color at the injection site,
  • signs of infection (e.g., fever, persistent sore throat, cough),
  • easy bruising or bleeding,
  • fast or irregular heartbeat,
  • sudden increase in weight,
  • swelling hands/legs/feet,
  • severe stomach or abdominal pain,
  • yellowing eyes or skin, or
  • dark urine.

QUESTION

What kind of disease is multiple sclerosis? See Answer

What Is Mavenclad?

Mavenclad (cladribine) is a purine antimetabolite indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, use of Mavenclad is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS.

What is Rebif?

Rebif (interferon beta-1a) Injection is made from human proteins and is used to treat relapsing multiple sclerosis (MS). Rebif will not cure MS; it will only decrease the frequency of relapse symptoms. Common side effects of Rebif include pain, swelling, or redness at the injection site. Flu-like symptoms such as headache, dizziness, fatigue, fever, chills, stomach pain, runny or stuffy nose, and muscle aches may occur when you first start Rebif. These symptoms usually improve or go away after a few months of continued use of Rebif. Some patients using interferon medications such as Rebif become depressed or have suicidal thoughts. Tell your doctor immediately if this occurs.

What Drugs Interact With Mavenclad?

Mavenclad may interact with immunosuppressive drugs, hematotoxic drugs, antiviral and antiretroviral drugs, ritonavir, eltrombopag, curcumin, cyclosporine, dilazep, nifedipine, nimodipine, cilostazol, sulindac, dipyridamole, reserpine, interferon-beta, corticosteroids, rifampicin, St. John's wort, or hormonal contraceptives. Tell your doctor all medications and supplements you use. Mavenclad is not recommended for use during pregnancy; it may harm a fetus. Pregnancy should be excluded before the initiation of each treatment course of Mavenclad. Females of reproductive potential should prevent pregnancy by use of effective contraception during Mavenclad dosing and for at least 6 months after the last dose in each treatment course. Males of reproductive potential should take precautions to prevent pregnancy of their partner during Mavenclad dosing and for at least 6 months after the last dose in each treatment course. Because of the potential for serious adverse reactions in nursing infants, Mavenclad is not recommended for use while breastfeeding.

What Drugs Interact With Rebif?

Rebif may interact with other drugs. Tell your doctor all medications and supplements you take. Talk to your doctor about how to drink alcohol safely while using this medication. Rebif should not be used during pregnancy. Talk to your doctor if you are pregnant or think you might become pregnant during treatment. Consult your doctor before breastfeeding.

How Should Mavenclad be Taken?

The cumulative dosage of 3.5 mg/kg Mavenclad is administered orally and divided into 2 treatment courses (1.75 mg/ kg per treatment course). Each treatment course is divided into 2 treatment cycles.

How Should Rebif be Taken?

The recommended dosage of Rebif is 22 mcg to 44 mcg injected subcutaneously three times per week. Rebif is intended for use under the supervision of a physician. Patients may self-inject only after proper training.

SLIDESHOW

What Is Multiple Sclerosis? MS Symptoms, Causes, Diagnosis See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Serono. Mavenclad Product Information

www.mavenclad.com/?

EMD Serono. Rebif Product Information

www.rebif.com/?

Health Solutions From Our Sponsors